Business & Industry

Swiss drugmaker Roche has expanded its artificial intelligence infrastructure by deploying more than 2,100 NVIDIA chips, strengthening its computational capabilities to accelerate drug and diagnostics development. The move, centred on a large-scale Roche AI factory, reflects the company’s ongoing...

Novartis has received approval from the US Food and Drug Administration (FDA) for Cosentyx (secukinumab) for the treatment of paediatric patients aged 12 years and above with moderate to severe hidradenitis suppurativa (HS). The FDA approval expands the therapy’s...

Neuland Laboratories is preparing to launch a new commercial peptide manufacturing facility at its 17-acre Bonthapally manufacturing campus, with the first phase expected to become operational in the summer of this year. The project forms part of a broader...

The U.S. Food and Drug Administration on Tuesday authorized the use of leucovorin, a long-established generic medicine, for the treatment of a rare genetic disorder associated with autism-like symptoms. The decision does not extend to children diagnosed with autism...

The UK government and national regulators have introduced a coordinated regulatory roadmap aimed at enabling space-based drug manufacturing, marking a significant step toward commercialising drug production in microgravity environments. The initiative brings together the UK Space Agency, the Medicines...

Taiwan is preparing a four-year national pharmaceutical resilience preparedness program designed to strengthen its domestic drug supply, supported by a 24 billion new Taiwan dollar ($755 million) investment. The initiative is intended to reinforce the country’s ability to maintain...

Norgine has confirmed a £23 million ($31 million) investment in its manufacturing facility in Hengoed, Wales, increasing the total capital directed toward the site to more than £50 million ($67 million) since 2022. The move is intended to strengthen...